Terms: = Lymphoma AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Clinical Outcome
10 results:
1. Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel.
Sams L; Kruger S; Heinemann V; Bararia D; Haebe S; Alig S; Haas M; Zhang D; Westphalen CB; Ormanns S; Metzger P; Werner J; Weigert O; von Bergwelt-Baildon M; Rataj F; Kobold S; Boeck S
Clin Transl Oncol; 2021 Nov; 23(11):2394-2401. PubMed ID: 33876417
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
[TBL] [Abstract] [Full Text] [Related]
3. Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.
Oguejiofor K; Hall J; Slater C; Betts G; Hall G; Slevin N; Dovedi S; Stern PL; West CM
Br J Cancer; 2015 Sep; 113(6):886-93. PubMed ID: 26313665
[TBL] [Abstract] [Full Text] [Related]
4. Expression of PD-1 (CD279) and foxp3 in diffuse large B-cell lymphoma.
Ahearne MJ; Bhuller K; Hew R; Ibrahim H; Naresh K; Wagner SD
Virchows Arch; 2014 Sep; 465(3):351-8. PubMed ID: 25011996
[TBL] [Abstract] [Full Text] [Related]
5. Expression of the T-cell regulatory marker foxp3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract] [Full Text] [Related]
6. clinical significance of tumor-infiltrating foxp3+ T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Kim KH; Kim TM; Go H; Kim WY; Jeon YK; Lee SH; Kim DW; Khwarg SI; Kim CW; Heo DS
Cancer Sci; 2011 Nov; 102(11):1972-6. PubMed ID: 21812857
[TBL] [Abstract] [Full Text] [Related]
7. CD4 (+)CD25 (+)foxp3 (+) regulatory T cells and hematologic malignancies.
Kelley TW; Parker CJ
Front Biosci (Schol Ed); 2010 Jun; 2(3):980-92. PubMed ID: 20515837
[TBL] [Abstract] [Full Text] [Related]
8. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.
Wahlin BE; Aggarwal M; Montes-Moreno S; Gonzalez LF; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
Clin Cancer Res; 2010 Jan; 16(2):637-50. PubMed ID: 20068089
[TBL] [Abstract] [Full Text] [Related]
9. Increased quantity of tumor-infiltrating foxp3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.
Kim WY; Jeon YK; Kim TM; Kim JE; Kim YA; Lee SH; Kim DW; Heo DS; Kim CW
Ann Oncol; 2009 Oct; 20(10):1688-96. PubMed ID: 19542249
[TBL] [Abstract] [Full Text] [Related]
10. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.
de Jong D; Koster A; Hagenbeek A; Raemaekers J; Veldhuizen D; Heisterkamp S; de Boer JP; van Glabbeke M
Haematologica; 2009 Jan; 94(1):70-7. PubMed ID: 19059937
[TBL] [Abstract] [Full Text] [Related]
